InvestorsHub Logo
Followers 17
Posts 1580
Boards Moderated 0
Alias Born 02/07/2007

Re: None

Monday, 11/11/2019 8:54:49 AM

Monday, November 11, 2019 8:54:49 AM

Post# of 429588
Adam Feuerstein putting out negative info.

"As
@matthewherper
noted on our internal Slack, if US patients taking Vascepa showed a greater benefit than overall patient population in REDUCE-IT, ex-US patients had a worse outcome. How much worse? $AMRN doesn’t say. Maybe FDA will tomorrow.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News